Great innovation doesnt fail from lack of intelligence. It fails from lack of orchestration.
Most founders assemble their commercialization path piece by piece- buidling in silos between clinical, funding, regulatory with single contacts and no connection. Synera built the whole path under one roof.
Synera Advisory is the clinical intelligence core of an integrated healthcare innovation ecosystem. Commercialization has its own language and network that takes a career to build. Everyone on the Synera team has stood where you are standing: a real clinical insight, a prototype or plan, and a full-time schedule.
Breakthroughs emerge from structured collaboration, multi-disciplinary teams, rigorous peer review, and disciplined evidence generation. Synera applies the collaborative architecture of academic research to the discipline of bringing innovation to market. Physician-led, evidence-driven, and agnostic.
Our capabilities parallel the translational curriculum-from clinical hypothesis to real-world adoption
Clinical Strategy and Validation
The unmet need you observe in practice is hypothesis; commercialization demands it be tested. We construct the indication strategy, evidence-generation architecture, and clinical study design that transform observed need into defensible clinical value with adoption strategy informed by physicians who understand what actually shifts practice patterns.
Regulatory and Compliance Navigation
Regulatory science is a discipline in its own right, with methodology as exacting as any subspecialty. We design pathway strategy across FDA-510(k), DeNovo, PMA,
EU-MDR/IVDR and UKCA surfacing quailty-system and data governance exposure early; the regulatory equivalent of identifying cofounders before the study begins.
Commercial and Market Access
Market access is applied health economics. We bring reimbursement and coding analysis, pricing and health-economic modeling, buying-center characterization, and go-to-market sequencing grounded in the empirical realities of health system procurement-the domain clinical training never covered.
The Synera Ecosystem
Jordan Morrison, Founder / Principal Managing Partner
Hakeem Adebiyi, Global Market Strategist / Founder Kairos Accelerator
Jordan Morrison, Founder / Principal Managing Partner
Managing Partner
Convergence Health Capital
Founder
Nexus Health Alliance
Founder
Kairos Accelerator
Jordan Morrison is a healthcare innovation strategist, ecosystem builder, and commercialization executive focused on advancing promising technologies from concept to patient bedside.
As Founder and Principal of Synera Advisory, she leads a phy
Managing Partner
Convergence Health Capital
Founder
Nexus Health Alliance
Founder
Kairos Accelerator
Jordan Morrison is a healthcare innovation strategist, ecosystem builder, and commercialization executive focused on advancing promising technologies from concept to patient bedside.
As Founder and Principal of Synera Advisory, she leads a physician-backed advisory platform that integrates clinical intelligence, regulatory strategy, commercialization, strategic partnerships, and capital readiness to help healthcare innovators reduce risk and build scalable companies.
She also seres as Managing Partner of Convergence Health Capital, a physician-informed Medtech investment platform supporting early-stage healthcare technologies through disciplined diligence, strategic guidance, and aligned capital.
As founder of Nexus Health Alliance Jordan is building a collaborative network of physicians, healthcare organizations, and industry partners designed to strengthen independent healthcare, expand access to innovation, and create new opportunities for true evidence based and value based care.
Through Kairos Medtech Accelerator, she leads an intensive launch program that helps founders validate their strategy, address critical commercialization gaps, and build the infrastructure needed to move decisively toward funding, market entry, and adoption.
Across each organization, Jordan's work is guided by one principal: innovation creates meaningful impact only when it successfully reaches the patient.
Mike Mayszak, -Fractional CFO/ B.S. Eng, MBA Finance
Hakeem Adebiyi, Global Market Strategist / Founder Kairos Accelerator
Jordan Morrison, Founder / Principal Managing Partner
Mike Mayszak is a strategic product and commercialization executive with more than 20 years of experience bringing complex technologies to market.
At Synera Advisory, Mike strengthens our commercialization ecosystem by helping founders translate innovative ideas into market-ready solutions through product strategy, go-to-market execution,
Mike Mayszak is a strategic product and commercialization executive with more than 20 years of experience bringing complex technologies to market.
At Synera Advisory, Mike strengthens our commercialization ecosystem by helping founders translate innovative ideas into market-ready solutions through product strategy, go-to-market execution, channel development, and business growth. His enterprise leadership across fortune 500 organizations enable Synera clients to build scalable products, align with customer needs, and accelerate sustainable commercial success.
Hakeem Adebiyi, Global Market Strategist / Founder Kairos Accelerator
Hakeem Adebiyi, Global Market Strategist / Founder Kairos Accelerator
Hakeem Adebiyi, Global Market Strategist / Founder Kairos Accelerator
Founder Kairos Accelerator
CEO Hands Associates
Hakeem Adebiyi is a global MedTech commercialization executive specializing in international market expansion, distribution strategy, and cross-border growth.
As Founder and Principal of Kairos Accelerator and CEO of Hands Associates, he has helped healthcare innovators successfully navigate c
Founder Kairos Accelerator
CEO Hands Associates
Hakeem Adebiyi is a global MedTech commercialization executive specializing in international market expansion, distribution strategy, and cross-border growth.
As Founder and Principal of Kairos Accelerator and CEO of Hands Associates, he has helped healthcare innovators successfully navigate complex global markets through proven commercialization frameworks, strategic partnerships, and scalable market entry strategies.
Within the Synera ecosystem, Hakeem extends our physician-led commercialization platform beyond the US by helping founders identify international growth opportunities, develop global-go-to-market strategies, build high value distribution networks, and execute market expansion across Europe, the UK, and other emerging healthcare markets. Heis expertise ensures commercialization strategies are aligned with regulatory pathways, reimbursement realities, channel development,, and sustainable international growth.
Casey Barton, Founder and Managing Partner
Hakeem Adebiyi, Global Market Strategist / Founder Kairos Accelerator
Hakeem Adebiyi, Global Market Strategist / Founder Kairos Accelerator
Founder and CEO Trivent Medical
Managing Partner
Convergence Health Capital
Casey Barton is a Certified Registered Nurse Anesthetist (CRNA), medical device innovator, and healthcare entrepreneur with more than 15 years of frontline clinical experience in anesthesia, airway management, and perioperative patient safety. His experience inspir
Founder and CEO Trivent Medical
Managing Partner
Convergence Health Capital
Casey Barton is a Certified Registered Nurse Anesthetist (CRNA), medical device innovator, and healthcare entrepreneur with more than 15 years of frontline clinical experience in anesthesia, airway management, and perioperative patient safety. His experience inspired the development of Trivent Medical, a patented airway management platform designed to improve patient safety and clinical outcomes. As Founder and CEO of Trivent Medical, Casey combines clinical expertise with product innovation to address unmet needs in airway management.
Within the Synera ecosystem, Casey represents the clinician-founder partnering with Synera to commercialize Trivent Medical while contributing practical insight into product development, regulatory strategy, and market adoption. As General Partner of Convergence Health Capital, he also helps identify and support transformative healthcare innovations with strong clinical and commercial potential.
Rob Matzkin, Founder / Chief Revenue Officer / 1Exit Venture Capital
Rob Matzkin, Founder / Chief Revenue Officer / 1Exit Venture Capital
Rob Matzkin, Founder / Chief Revenue Officer / 1Exit Venture Capital
Rob Matzkin is an enterprise growth executive with extensive experience scaling technology companies through commercialization, revenue strategy, and operational leadership. As a former CEO, CRO, investor and advisor, he specializes in building high-performing go-to-market organizations and guiding companies through growth, fundraising an
Rob Matzkin is an enterprise growth executive with extensive experience scaling technology companies through commercialization, revenue strategy, and operational leadership. As a former CEO, CRO, investor and advisor, he specializes in building high-performing go-to-market organizations and guiding companies through growth, fundraising and strategic partnerships.
At Synera Advisory, Rob leads commercialization strategy and enterprise growth initiatives, helping founders develop scalable revenue models, strengthen market positioning, and execute successful go to-to-market strategies. His expertise bridges innovation and commercial execution, ensuring breakthrough healthcare technologies are built to achieve sustainable market success.
David Pennington, RN, BSN, MBA / CEO -5 Exits
Rob Matzkin, Founder / Chief Revenue Officer / 1Exit Venture Capital
Rob Matzkin, Founder / Chief Revenue Officer / 1Exit Venture Capital
David Pennington, RN, BSN, MBA is a healthcare executive with extensive experience scaling MedTech and life science companies through commercialization, strategic growth, and executive leadership. With a track record spanning multiple successful exits, global sales leadership, and board advisory roles, he specializes in transforming innov
David Pennington, RN, BSN, MBA is a healthcare executive with extensive experience scaling MedTech and life science companies through commercialization, strategic growth, and executive leadership. With a track record spanning multiple successful exits, global sales leadership, and board advisory roles, he specializes in transforming innovative technologies into market leading businesses.
At Synera Advisory, David leads commercialization strategy and market expansion iniitatives, leveraging his clinical background and executive expertise to help founders build high-performing commercial organizations, establish strategic partnerships, and accelerate adoption of breakthrough healthcare innovations. His experience compliments Synera's physician-backed ecosystem by ensuring exceptional technologies achieve lasting commercial success.
Chad Zoretic, Mergers and Acquisitions Investor
Rob Matzkin, Founder / Chief Revenue Officer / 1Exit Venture Capital
David Pudwill Regulatory and Quality Strategy Advisor
Chad Zoretic is a nationally recognized healthcare transaction and strategy executive specializing in mergers and acquisitions, capital strategy, and enterprise value creation. With decades of experience advising healthcare providers, digital health innovators medical device companies, and private equity investors, he helps organizations
Chad Zoretic is a nationally recognized healthcare transaction and strategy executive specializing in mergers and acquisitions, capital strategy, and enterprise value creation. With decades of experience advising healthcare providers, digital health innovators medical device companies, and private equity investors, he helps organizations maximize growth through disciplined financial strategy and transaction execution.
At Synera Advisory, Chad provides executive guidance on strategic partnerships, capital planning due diligence. and exit readiness. His expertise compliments Synera's physician-backed commercialization platform by helping innovative healthcare companies become investment ready, execute strategic transactions, and create lasting enterprise value.
David Pudwill Regulatory and Quality Strategy Advisor
Rob Matzkin, Founder / Chief Revenue Officer / 1Exit Venture Capital
David Pudwill Regulatory and Quality Strategy Advisor
David Pudwill is one of Synera Advisory's Strategic Regulatory Partners, bringing nearly two decades of FDA and medical device leadership across regulatory affairs, quality systems, and clinical strategy.
As a former FDA reviewer and Fractional Chief Regulatory Officer, David helps innovators navigate complex global regulatory pathways, de
David Pudwill is one of Synera Advisory's Strategic Regulatory Partners, bringing nearly two decades of FDA and medical device leadership across regulatory affairs, quality systems, and clinical strategy.
As a former FDA reviewer and Fractional Chief Regulatory Officer, David helps innovators navigate complex global regulatory pathways, de-risk product development, and build submission strategies that accelerate commercialization. His expertise strengthens Synera's physician-led ecosystem by ensuring regulatory strategy is aligned with clinical evidence, reimbursement, investor readiness, and successful market adoption from concept through commercialization.
Our Services
Our Services
Our Services
We offer a variety of healthcare services that cater to the diverse needs of our patients. Our services include primary care, specialty care, diagnostic testing, and more.